Tetrahydrocannabinol
Tetrahydrocannabinol is a pharmaceutical drug with 10 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
3
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
0
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Warrior CARE: Cannabis Behavioral Health
Anesthetic Premedication With a Cannabis Extract (Cannapremed)
The Role of the Endocannabinoid System in Sweet Taste Intensity and Liking
Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
Effects of THC and CBD on Human Episodic Memory Function
Clinical Trials (10)
Warrior CARE: Cannabis Behavioral Health
Anesthetic Premedication With a Cannabis Extract (Cannapremed)
The Role of the Endocannabinoid System in Sweet Taste Intensity and Liking
Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
Effects of THC and CBD on Human Episodic Memory Function
Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain
The Analgesic Efficacy of Δ9-THC (Namisol®) in Patients With Persistent Postsurgical Abdominal Pain
Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD)
Responses to Marijuana-Related Cues Versus Neutral Cues in Adults Taking Tetrahydrocannabinol (THC) - 2
Efficacy Trial of Oral Tetrahydrocannabinol in Patients With Fibromyalgia
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10